Neuroinflammation in Patients With OCD

Summary

The goal of this study is to examine whether measurements of inflammation from brain scanning and blood tests can predict how much benefit patients with obsessive-compulsive disorder (OCD) will have from treatment with an anti-inflammatory medication, celecoxib, when adding to ongoing medication-based treatment for OCD.

Timeline

Start

2021-04-01

Primary completion

2026-08

Completion

2026-08

Outcome

Outcome not reported

Stopped: “The NYSPI site is currently paused and has been paused since an institutional pause on human subjects research on March 14, 2024.”

Drugs

Indications